...We Welcome You To The Resverlogix HUB On AGORACOM!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Eastern exercised some $0.90 cent warrants

Thanks GAC. I found the press release from 2013:

RESVERLOGIX CLOSES $1.6 MILLION PRIVATE PLACEMENT

Looks like the warrants were set to expire next week. $476,632.89 for the company! I think that much cash covers around a week of operations.

I hope Eastern holds the newly acquired shares.

Share
New Message
Please login to post a reply